![Currien MacDonald staff image](https://www.wcgclinical.com/wp-content/uploads/2020/07/currien-macdonald-300x300.png)
Currien MacDonald, MD, CIP
IRB Chair, WCG IRB
Biography
Dr. Currien MacDonald is the chair of WCG IRB panel 1 and contributes to biosafety reviews for WCG’s institutional biosafety committee. Prior to joining WIRB, Dr. MacDonald served for four years as the medical director for Aspire IRB, another WCG company, and vice-chair of Canadian REB.
After graduating top of his class from the University of Minnesota Medical School, Dr. MacDonald completed a rigorous family medicine residency program as chief resident. He then delivered primary care for five years in San Diego, CA. After that period, he served as a medical consultant to the University of California, San Diego on a groundbreaking prisoner healthcare reform project.
Dr. MacDonald completed certification programs in clinical trials administration and medical acupuncture. He is also a certified IRB professional (CIP) with Public Responsibility in Medicine and Research (PRIM&R), the national organization for the protection of human subjects in research. In addition, Dr. MacDonald is a member of the American Academy of Family Physicians, American Medical Association, and the American Medical Writers Association.
Latest insights by Currien
![](https://www.wcgclinical.com/wp-content/uploads/2022/02/expanded-access-doctor-patient.jpg)
The Basics of the Individual Expanded Access Request Process: A Resource for Physicians
Whitepapers![](https://www.wcgclinical.com/wp-content/uploads/2021/01/nurse-patient-waiting-room-form.jpg)
Providing Research Participants with New Information: Is “Re-Consent” Always Necessary?
Whitepapers![](https://www.wcgclinical.com/wp-content/uploads/2020/12/report-review.jpg)
What are IRB submission requirements for post marketing safety reports?
Blog Posts![](https://www.wcgclinical.com/wp-content/uploads/2020/07/itemeditorimage_5f109f472e55e.png)
Submitting Deviations from a Sponsor’s Adverse Event Reporting Requirements to the IRB
Blog Posts![](https://www.wcgclinical.com/wp-content/uploads/2020/07/itemeditorimage_5db1c00f8a6a0.jpg)
What are the Blood Draw Guidelines for Phase 1 Clinical Trials?
Blog Posts![](https://www.wcgclinical.com/wp-content/uploads/2020/07/infectious-disease-challenge-studies-600x400-1.jpg)
Infectious Disease Challenge Studies: Ethical Issues in Causing Disease for Medical Knowledge
Whitepapers![](https://www.wcgclinical.com/wp-content/uploads/2020/07/biomarker-and-diagnostic-tests-600x400-1.jpg)
Under the Microscope: Biomarker and Diagnostic Tests as FDA-Regulated Devices
Whitepapers![](https://www.wcgclinical.com/wp-content/uploads/2020/07/human-cells-600x400-1.jpg)